aTyr Pharma Expands Board

San Diego-based aTyr Pharma announced this morning that it is expanding its board of directors, adding independent director Jeffrey S. Hatfield to its board. Hatfield was most recently President and Chief Executive Officer of Vitae Pharmaceuticals. Hatfield served in that position from March 2004 until October 2016, when Vitae was acquired by Allergan for $639M. Hatfield also served at Bristol-Myers Squibb.